Additionally, this study aims to explore the potential impact of OPG on breast cancer risk in individuals carrying BRCA1/2 mutations, to elucidate the underlying mechanisms contributing to breast tumorigenesis and progression. Here, TNFRSF11B is linked to breast cancer.